Magnetic Resonance Imaging + Biopsy Procedure + Bone Marrow Aspiration + Bone Marrow Biopsy + Clinical Observation + Computed Tomography + Ultrasound + ETOPOSIDE + Doxorubicin hydrochloride + Cyclophosphamide + Carboplatin for ganglioneuroblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Jun 2014: Trial registered, NCT02176967
  2. 8 Aug 2014: Trial started, NCT02176967

The trials

NCT02176967: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

State
Under way
Phase
Phase 3
People
391 taking part
Started
8 Aug 2014
Primary completion
30 Sep 2026
Arms
Group B (clinical observation, first-line chemotherapy), Group C (clinical observation, first-line chemotherapy)
Results
None posted
  1. 27 Jun 2014: Trial registered
  2. 8 Aug 2014: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.